Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
Delivery Driver Robbed of $16K Ozempic, Mounjaro in PA - Featured image
GLP-1 Medications

Delivery Driver Robbed of $16K Ozempic, Mounjaro in PA

Shotlee Editorial Team
Written by Shotlee Editorial TeamHealth Research & Writing
·January 18, 2026·2 min read

On this page

  • The Robbery Details
  • Suspects Identified and Charged
  • Rising Thefts and Scams for GLP-1 Drugs

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

A delivery driver was robbed of $16,000 worth of Ozempic, Mounjaro, and Trulicity outside a Bensalem, PA pharmacy. Three suspects from New York were quickly arrested after assaulting the driver. Rising demand for GLP-1 medications fuels thefts and scams, per KFF survey and BBB alerts.

Share

On this page

  • The Robbery Details
  • Suspects Identified and Charged
  • Rising Thefts and Scams for GLP-1 Drugs

A delivery driver faced a brazen robbery outside Smart Choice Pharmacy in Bensalem, Pennsylvania, losing two boxes of Ozempic, Mounjaro, and Trulicity valued at $16,000.

The Robbery Details

Early Thursday morning, three suspects from New York assaulted the driver and fled in a gold-colored Toyota, nearly hitting a witness recording the incident. Bensalem police received a 911 call with a vehicle description and located the suspects nearby.

The pharmacy had reported suspicious calls and emails about deliveries in the days prior.

Suspects Identified and Charged

  • 41-year-old Joshua Dupree of Tamaqua, PA
  • 21-year-old Jahnoi Dawkins of Albany, NY
  • 17-year-old male from New York City

All three were positively identified by the victim. They face charges of robbery, theft, receiving stolen property, simple assault, and related offenses.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

Dupree and Dawkins had bail set at $150,000 and $250,000 respectively by Magisterial District Judge Michael Gallagher. They are detained at Bucks County Correctional Facility, while the juvenile is at Bucks County Youth Detention Center.

Rising Thefts and Scams for GLP-1 Drugs

Thefts targeting GLP-1 medications like Ozempic and Trulicity are increasing as demand surges. A 2024 KFF survey found about 6% of Americans using these drugs for diabetes and weight loss.

The Better Business Bureau (BBB) warns of fake messages, online pharmacy ads, and impostor doctor offers pushing counterfeit GLP-1 drugs. High demand for these popular weight-loss treatments is driving scam proliferation.

Source Information

Originally published by Breitbart.Read the original article →

Read next

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

What's the Deal with Peptides? The Hyped Market Under FDA Review
Health & Wellness

What's the Deal with Peptides? The Hyped Market Under FDA Review

An in-depth look at the FDA's review of unregulated peptide therapy, the safety concerns raised by experts, and the conflict between industry demand and clinical evidence.

8 min read
Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program
Health & Wellness

Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program

Learn how the new Medicare GLP-1 Bridge program works, which drugs are covered, and why major pharmaceutical companies are leading the awareness push for the $50 copay initiative.

8 min read
Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials
Medical Research

Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials

Eli Lilly's investigational drug, retatrutide, has shown promising results in clinical trials, offering substantial weight loss and significant improvements in cardiovascular health and type 2 diabetes management.

7 min read

Same topic: Ozempic

All Ozempic articles →
Samsung Biologics Acquires PolyPeptide for $1.8 Billion to Expand Peptide Therapeutics
Pharmaceutical Industry News

Samsung Biologics Acquires PolyPeptide for $1.8 Billion to Expand Peptide Therapeutics

Samsung Biologics has announced a major acquisition of PolyPeptide Group AG for $1.8 billion, marking a strategic expansion into the rapidly growing peptide therapeutics market, particularly for GLP-1 drugs.

8 min read

More in GLP-1 Medications

What to Know If Taking Weight Loss Drugs Like Ozempic
GLP-1 Medications

What to Know If Taking Weight Loss Drugs Like Ozempic

Roughly half a million Australians are using GLP-1 weight loss drugs like Ozempic and Mounjaro, with some reporting life-changing results while others face side effects. Professor Kelly Lambert from the University of Wollongong shares key insights on what you need to know. This guide covers mechanisms, safety, and practical tips for users.

5 min read
Millennial Stars Admit to Ozempic & GLP-1 Use: Transformations
GLP-1 Medications

Millennial Stars Admit to Ozempic & GLP-1 Use: Transformations

Midlife weight gain is hitting millennial stars hard, but many are turning to Ozempic and other GLP-1s for help. Celebrities including Amy Schumer, Golnesa 'GG' Gharachedaghi, and Serena Williams have openly admitted to using these medications, sharing their triumphs, side effects, and transformations. Discover their stories and the science behind these popular drugs.

5 min read
Novo's Woes Despite Ozempic's Explosive Growth
GLP-1 Medications

Novo's Woes Despite Ozempic's Explosive Growth

Novo Nordisk's Ozempic pioneered the GLP-1 revolution, tripling sales to 309 billion DKK in eight years. Yet shares have cratered 60% due to Eli Lilly's Mounjaro gains, trial disappointments, and looming generics. Discover the booming market's challenges and opportunities.

5 min read
Share this article
  1. Home
  2. Blog
  3. Delivery Driver Robbed of $16K Ozempic, Mounjaro in PA
Shotlee Editorial Team — Health Research & Writing
Written by

Shotlee Editorial Team

Health Research & Writing

Shotlee’s guides and articles are researched and written in-house by the Shotlee Editorial Team. We build every page from primary sources — FDA labels, official prescribing information, and peer-reviewed clinical trials — and cite them directly. Our content is educational and is not a substitute for advice from your own healthcare provider.

View all articles by Shotlee Editorial Team
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community